Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association Between Prediagnostic Risk Factors and Survival After Colorectal Cancer Diagnosis in Golesten Cohort Study Publisher Pubmed



Yadegar A1 ; Dalvand S2 ; Sharafkhah M1 ; Sepanlou SG3 ; Poustchi H1 ; Roshandel G4 ; Sheikh M5 ; Sadjadi A1 ; Mohammadi F1 ; Masoudi S1 ; Malekzadeh R1 ; Rezaei N3 ; Delavari A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Epidemiology and Biostatistics, School of Health, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
  5. 5. Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France

Source: Scientific Reports Published:2025


Abstract

This study investigated the survival rates of colorectal cancer (CRC) and the association between several pre-diagnostic factors, including demographic, anthropometric, behavioral, nutritional, lifestyle, and medical history and CRC incidence and survival. Among 50,045 participants in the Golestan cohort study, 190 patients diagnosed with CRC during the follow-up period were included in this study. Cox regression and Kaplan–Meier were used for analysis. The CRC incidence risk was significantly higher in males (HR = 2.20; 1.54–3.14), adults aged 50–70 years (HR = 1.86, 1.36–2.55), adults aged 70 years and older (HR = 3.71; 2.13–6.44), and urban dwellers (HR = 1.74; 1.22–2.47). The 1-year, 2-year, and 5-year overall survival was 60.3%, 47.5%, and 35.2%, respectively. Higher pre-diagnostic socio-economic status (SES) was associated with a significantly decreased mortality (HR = 0.55; 0.34–0.89). While, age 70 years and older (HR = 2.79; 1.12–6.99), pre-diagnostic opium use (HR = 2.35; 1.36–4.07), and metastasis (HR = 2.97; 1.97–4.48) were associated with a significantly increased mortality. Health policies should be implemented to enhance healthcare services and screening programs in low-SES areas. The general population, especially males and adults aged 50 years and older should be informed about CRC screening, CRC symptoms, and healthy lifestyles and diets. Furthermore, there is a critical need to raise awareness about the harmful effects of opium on CRC. © The Author(s) 2025.
Other Related Docs
14. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study, Cancer Epidemiology Biomarkers and Prevention (2018)
31. Incidence, Early Case Fatality and Determinants of Stroke in Iran: Golestan Cohort Study, Journal of Stroke and Cerebrovascular Diseases (2022)
38. Oral Health and Mortality in the Golestan Cohort Study, International Journal of Epidemiology (2017)